Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Trading Statement

12 Jul 2007 07:00

Cello Group plc12 July 2007 12 July 2007 Cello Group plc Pre Close Trading Statement - six months to 30 June 2007 Cello Group plc ("Cello" AIM: CLL), the research and consulting group, todayprovides the following pre-close trading update for the six months to 30 June2007. Cello has continued to make good progress and the Board is confident about theGroup's outcome for the full year. The research and consulting business continues to perform well and on a fullyear basis is expected to deliver healthy growth. Our response business will bemore heavily second half weighted than in the past, but given good revenuevisibility which has strengthened since the AGM statement on 22 May, we areconfident about the full year outcome for this business. Our research and consulting business which now accounts for around 75% of theGroup on an operating profit basis has benefited from the investments made innew staff and product offering during the course of 2006 and the first half of2007. We have seen significant revenue growth from existing clients as well as anumber of large new client wins, particularly internationally. Internationalwork now accounts for 45% of the revenues of this division. The size ofcontracts we are pitching for and also winning has increased markedly, helpingdrive good like for like revenue growth. During the first six months of 2007, we further strengthened our healthcareresearch and consulting capability with the acquisition of The MSI Consultancyin March. In June, mruk research also joined the Group, strengthening ourresearch offer to the public sector. We have also made significant strides in building our online research business.In February we acquired a controlling interest in Digital People and Rosenblatt,and more recently we purchased a significant minority share in nqual, a dynamiconline qualitative research company. Our response business which comprises 25% of the Group continues to build astrong position in the sector, with healthy like for like revenue growth basedon good levels of revenue visibility. The seasonal split between the first andsecond half has continued to widen as the growth of the business has seen aparticular focus on clients with a seasonal spending pattern in both charitiesand financial services. This seasonality will affect like for like growth at aprofit level for the six months to 30 June but not on a full year basis where weare confident of good profit growth. We continue to increase the online component of our response offering, boththrough our separate branded offerings, Blonde and Oomph, as well as theincreasing component of our core offer that is now digital. On 6 July we announced the acquisition of cchm:ping, a specialist financialservices marketing agency and the establishment of a consulting offer in thissector vertical. In line with our prudent financing policy, Cello has maintained a strong balancesheet with low gearing. Cello expects to announce its interim results for the six months to 30 June 2007on Tuesday 11 September 2007. These results will be prepared under IFRS, and atransition statement will be issued prior to that date. Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8460 College HillAdrian Duffield/Ben Way 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building aportfolio of research and consulting businesses capable of advising blue chipclients globally. Cello has annualised turnover in excess of ÂŁ100million, gross profits of overÂŁ50 million and employs approx 650 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Jan 20157:00 amRNSPRE-CLOSE TRADING STATEMENT
16th Jan 20155:15 pmRNSBlocklisting Interim Review
6th Jan 20154:50 pmRNSTotal Voting Rights
9th Dec 20147:00 amRNSAcquisition of Worldwide Promedica Inc
28th Nov 20141:10 pmRNSTotal Voting Rights
3rd Nov 201410:58 amRNSTotal Voting Rights
2nd Oct 201410:59 amRNSDirector/PDMR Shareholding
1st Oct 20141:05 pmRNSTotal Voting Rights
19th Sep 20144:10 pmRNSDirector/PDMR Shareholding
17th Sep 20147:00 amRNSInterim Results
1st Sep 20147:00 amRNSHolding(s) in Company
29th Aug 20147:00 amRNSTotal Voting Rights
31st Jul 20147:00 amRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Update
1st Jul 20143:54 pmRNSBlocklisting Interim Review
1st Jul 201412:24 pmRNSTotal Voting Rights
25th Jun 20141:27 pmRNSIssue of Equity
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
3rd Jun 20142:02 pmRNSDirector/PDMR Shareholding
30th May 20147:00 amRNSTotal Voting Rights
13th May 20141:00 pmRNSResults of Annual General Meeting
13th May 20147:00 amRNSAGM STATEMENT
13th May 20147:00 amRNSAcquisition of iS Healthcare Dynamics
8th May 20147:00 amRNSAdditional listing/TVR
30th Apr 20143:25 pmRNSTotal Voting Rights
25th Apr 20147:00 amRNSAcquisition of Line Digital
14th Apr 201412:17 pmRNSAnnual Report & Accounts 2013 & Notice of AGM
31st Mar 20147:00 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results for the Year Ended 31 Dec 2013
28th Feb 20147:00 amRNSTotal Voting Rights
3rd Feb 20147:00 amRNSTotal Voting Rights
22nd Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
7th Jan 20142:17 pmRNSBlocklisting Interim Review
17th Oct 201310:53 amRNSDirector/PDMR Shareholding
11th Oct 201311:36 amRNSTransaction in Own Shares
11th Oct 20137:00 amRNSDirector/PDMR Shareholding
1st Oct 20132:58 pmRNSTotal Voting Rights
27th Sep 201311:42 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSDirector/PDMR Shareholding
18th Sep 20137:00 amRNSInterim Results
13th Sep 201312:07 pmRNSIssue of Equity
17th Jul 20137:00 amRNSTrading update
8th Jul 201312:26 pmRNSTransaction in Own Shares
4th Jul 201310:00 amRNSDirector/PDMR Shareholding
14th Jun 20137:00 amRNSBlock Listing Application
3rd Jun 20133:12 pmRNSDirector/PDMR Shareholding
31st May 20139:00 amRNSTotal Voting Rights
21st May 201312:53 pmRNSDirector/PDMR Shareholding
15th May 201312:12 pmRNSHolding(s) in Company
14th May 20132:49 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.